|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 96 No. 1 (July 1), 2000:
pp. 297-306
Inhibition of in vitro spontaneous apoptosis by IL-7 correlates
with Bcl-2 up-regulation, cortical/mature immunophenotype, and better
early cytoreduction of childhood T-cell acute lymphoblastic
leukemia
Leonid Karawajew,
Velia Ruppert,
Christian Wuchter,
Annett Kösser,
Martin Schrappe,
Bernd Dörken, and
Wolf-Dieter Ludwig
From the Department of Hematology, Oncology, and Tumor Immunology,
Robert-Rössle Clinic, Charité, Humboldt University of
Berlin, Berlin; and the Department of Pediatrics, Medical School of
Hannover, Hannover, Germany.
In normal T-cell development, IL-7 plays a nonredundant role as an
antiapoptic factor by regulating Bcl-2 expression in pro-T cells. In
the current study, we addressed the roles of IL-7 and related cytokines
as apoptosis-modulating factors in precursor T-cell acute lymphoblastic
leukemia (T-ALL). To this end, leukemic blasts from pediatric patients
with T-ALL were prospectively investigated as to their responsiveness
to IL-7, IL-4, and IL-2 (in terms of modulation of spontaneous
apoptosis, assessed by flow cytometry), cytokine receptor expression
profiles, and expression levels of Bcl-2 and Bax proteins. IL-7, in
contrast to IL-4 and IL-2, was highly efficient in apoptosis inhibition
, and this effect correlated with the expression levels of IL-7R
chain and with the up-regulation of Bcl-2 protein expression (P
< .0001). Subclassification of T-ALL samples (n = 130)
according to their in vitro IL-7 responses revealed that IL-7
refractory samples were more frequently positive for CD34 (P
< .0001) and the myeloid-associated antigen CD33 (P = .01), whereas IL-7 responsiveness was associated with an
expression of more mature differentiation-associated T-cell antigens
(CD1a, surface CD3, CD4/8; P < .05). Furthermore, the extent
of apoptosis inhibition by IL-7 in vitro quantitatively correlated with
early cytoreduction as determined by the prednisone peripheral blood response on day 8 and cytoreduction in the marrow on day 15 (n = 87;
P < .05). Multivariate analysis of the apoptosis-related parameters investigated, including spontaneous apoptosis, its inhibition by IL-7, and expression levels of Bcl-2 and Bax, showed that
only IL-7 responsiveness has an independent impact on early cytoreduction (P < .05), thus indicating a potential
prognostic relevance of IL-7 sensitivity in T-ALL.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
K. A. Duthie, L. C. Osborne, L. J. Foster, and N. Abraham
Proteomics Analysis of Interleukin (IL)-7-induced Signaling Effectors Shows Selective Changes in IL-7R{alpha}449F Knock-in T Cell Progenitors
Mol. Cell. Proteomics,
October 1, 2007;
6(10):
1700 - 1710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nishiyama, K. Takaji, K. Kataoka, Y. Kurihara, M. Yoshimura, A. Kato, H. Ogawa, and H. Kurihara
Id1 Gene Transfer Confers Angiogenic Property on Fully Differentiated Endothelial Cells and Contributes to Therapeutic Angiogenesis
Circulation,
November 1, 2005;
112(18):
2840 - 2850.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Karawajew, P. Rhein, G. Czerwony, and W.-D. Ludwig
Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species
Blood,
June 15, 2005;
105(12):
4767 - 4775.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Barata, A. Silva, J. G. Brandao, L. M. Nadler, A. A. Cardoso, and V. A. Boussiotis
Activation of PI3K Is Indispensable for Interleukin 7-mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells
J. Exp. Med.,
September 7, 2004;
200(5):
659 - 669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Barata, V. A. Boussiotis, J. A. Yunes, A. A. Ferrando, L. A. Moreau, J. P. Veiga, S. E. Sallan, A. T. Look, L. M. Nadler, and A. A. Cardoso
IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL
Blood,
March 1, 2004;
103(5):
1891 - 1900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. P. McCormack and T. H. Rabbitts
Activation of the T-Cell Oncogene LMO2 after Gene Therapy for X-Linked Severe Combined Immunodeficiency
N. Engl. J. Med.,
February 26, 2004;
350(9):
913 - 922.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. I. Brown, J. Fang, K. Alcorn, R. Barr, J. M. Kim, R. Wasserman, and S. A. Grupp
Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling
PNAS,
December 9, 2003;
100(25):
15113 - 15118.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al.
Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia
Cancer Res.,
October 1, 2003;
63(19):
6469 - 6477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wuchter, V. Ruppert, M. Schrappe, B. Dorken, W.-D. Ludwig, and L. Karawajew
In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia
Blood,
May 13, 2002;
99(11):
4109 - 4115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Barata, A. A. Cardoso, L. M. Nadler, and V. A. Boussiotis
Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27kip1
Blood,
September 1, 2001;
98(5):
1524 - 1531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
